Flow Technologies

Angel Medical Systems Inc, based in Eatontown, NJ, is the pioneering company behind the world's first and only FDA-approved heart attack warning system, known as the Guardian System. This innovative device provides continuous monitoring and real-time alerts for abnormal changes in heart activity, including silent heart attacks, ensuring immediate emergency response and decreased pre-hospital delay. With a focus on improving patient outcomes and reducing the risk of permanent heart damage, the Guardian System offers peace of mind and faster access to critical care. With a mission to address the unmet medical need for more effective diagnosis of life-threatening heart conditions, Angel Medical Systems Inc's Guardian System fills a crucial gap by providing early detection and warning of coronary occlusions, even in the absence of symptoms. By alerting patients to the onset of a heart attack and facilitating prompt transportation to the emergency room, the Guardian System has been proven to significantly reduce pre-hospital delay and improve the chances of obtaining timely medical treatment. With its groundbreaking technology and commitment to patient well-being, Angel Medical Systems Inc is revolutionizing the way heart attacks are detected and managed.Generated from the website

Chemo Dynamics, located in Sayreville, NJ, is a reputable chemical laboratory specializing in custom synthesis and process development for pharmaceutical companies. With a mission to be a valuable part of their clients' outsource team, they offer high-quality services that minimize time to market and help control costs. With a focus on efficiency and reliability, Chemo Dynamics provides a wide range of capabilities, including CRO (Contract Research Organization) and CMO (Contract Manufacturing Organization) services. Their expertise lies in the synthesis of amino acids, boronic acids, carbohydrates, chiral compounds, crown ethers, imidazoles, indoles, pyrimidines, small peptides, and steroids, making them a trusted partner in the pharmaceutical industry.Generated from the website

Cornerstone Pharmaceuticals is a biopharmaceutical company based in Cranbury, NJ, focused on developing innovative antimetabolic therapies for cancer treatment. The company is currently advancing its lead drug candidate, CPI-613 (devimistat), through preclinical models to explore its efficacy in combination therapies. With a commitment to research and development, Cornerstone Pharmaceuticals aims to revolutionize cancer care by targeting the metabolic pathways that fuel tumor growth. Their strategic approach reflects a dedication to improving patient outcomes through novel therapeutic solutions. Generated from the website